Pivot Pharmaceuticals (PVOTF) to Turn Up the Heat This Year
/

January 23, 2019

/

05:56 AM PST

Rating

Pivot Pharmaceuticals (PVOTF) is poised to take the biotech market by storm in 2016.

Action

Upgrade

Recommendation

Speculative Sell

Timeframe

Long-Term

Risk

High

Sack Lunch Productions (SAKL) Has Profits in the Bag

January 23, 2019

/

05:48 AM PST

Rating

No ratings

Sack Lunch Productions, Inc. (OTCMKTS:SAKL), the name behind Slide the City, is poised to reach a critical mass in 2016.

Symbol(s): SAKL
Action

Upgrade

Recommendation

Speculative Sell

Timeframe

Mid-Term

Risk

Medium